A look at the Current Situation of Iranian Molecular Diagnostic Methods and the Implementation of Required Future Policy: A Review Article.

Document Type : Review

Author

Department of Molecular Biology, Health Reference Laboratory, Ministry of Health and Medical Education, Tehran, Iran.

Abstract

Today, molecular diagnostic methods have an unignorably position in diagnostic laboratories. It is estimated that 60-70% of all decisions depend on molecular detection methods. However, many Iranian physicians still do not fully trust the newly developed protocols in particular. If necessary, they request some confirmatory tests available to ensure a final decision.
The purpose of this short study is to investigate the causes of uncertainty in these tests and current challenges in Iranian clinical centers. Therefore, all the effective cases from receiving the samples to publishing the patient reports are looked up.
Significant parameters including pre-analytical, analytical and post-analytical parameters are studied in this study. The reason for some of the current limitations is discussed based on released documents and reported periodic inspections according to published standard criteria. Based on the results, the need for fundamental revisions in some parts of the relevant bodies is clearly identified.

Keywords


Introduction
It is assumed that the results of diagnostic tests should be reliable and consistently interpretation in the same parts of a sample by different laboratories (1,4).
The importance of standardizing laboratory SOPs and minimizing uncertainties should be considered from the pre-analytical stage to the preparation of the final results (5,7).
Obviously, the quality of these results must be constantly increased. Diagnostic errors have been reported in all countries, causing permanent injury or even death to patients (18,13).
Patients and physicians are deeply concerned

about these errors in their health care system. Therefore, physicians request that, at least in some important cases, simultaneous testing be performed in two laboratories to make the correct interpretation and final decision.
At present, Iranian physicians often complain of uncertainty about the results (14,15).
These uncertainties, which are mostly related to molecular methods, may be due to several problems. Some of these problems may be due
to government policies. In this study, we try to explain some of the limitations and other chal
nges of clinical laboratories.

literature review
Laboratory materials and equipment
In order to perform the correct tests to achieve its laboratory mission, each laboratory must ensure its own equipment and verify its performance. In addition to the role of materials and equipment, the accuracy of the results depends on several other parameters from the receipt of specimens to the report of patients’ results.
Some studies report a range of 10-15% for diagnostic errors, while no research has been conducted on clinical diagnostic laboratories in Iran or documents have been published (16,17).
The National Medical Devices Directorate (NMDD) is a government office that approves required laboratory materials and devices (18,21).
Unfortunately, accrediting equipment, according to the complainant, takes a long time in the NMDD. Verification of unauthorized equipment has been reported in some cases.
Thus, this situation has caused medical centers to use invalid devices when needed. On the other hand, the lack of active supervision has also encouraged some laboratories to buy unqualified and cheap equipment and materials.

Definitions and Reference intervals
Each laboratory supplies the approved equipment according to the criteria and calculation methods of its country. Unfortunately, we have to procure many materials and kits from other countries. These resources are sourced in their own way from East Asia to the United States. Therefore, each laboratory may have its own definition based on the materials used and diagnostic kits with their own interpretations such as International Unite, dynamic range, quantitative calculation methods.
Reference intervals in the clinical laboratory are another widely used decision tool. This plays an important role in interpreting laboratory results. Several studies have revealed that reference intervals vary greatly, even when laboratories use the same method. Most reference intervals used are based on short laboratory studies, while they should be the result of valid clinical trial studies in Iran (22,23).
Obviously, this will lead to different clinical interpretations. Therefore, it increases the risk for patients and may cause unnecessary testing to be repeated. According to the Australian approach, the selecting of reference intervals requires evidence that needs to be evaluated by a checklist for different criteria.
There are currently no published documents or articles on this topic. Periodic inspections have shown that most General Directorate of Laboratory Affairs (GDLA)
do not have a clear view of checklists.
The Australians items are as follows
1-Definition of analyte.
2. Define assays used, accuracy and specificity of analyte.
3. Checking the interference the differences of pre-analytical procedures.
4. Define RI and its principle (e.g. central 95%).
5. Describe evidence for selection of common RIs data sources .
6. Consider partitioning based on age, sex, etc
7. Define degree of rounding.
8. Assess clinical considerations of the RI and use of common RI.
9. Document and implement.

Harmonization of analytical issues
Coordination of procedures in laboratory medicine is recognized as a need to improve the quality of diagnostic tests. Mismatch of analytical issues is one of the most influential parameters that is often ignored and can often lead to other problems (24,27).
Clinical and Laboratory Standards Institute (CLSI) and Joint Committee for Traceability in Laboratory Medicine (JCTLM) are two organizations that provide guidance on this issue. In addition, several other organizations have a key role to play in improving standardization and coordination of measurements (24,27).
CLSI and JCTLM are the two organization for providing guidelines at this issue. Besides, several other organizations have also original role on improvement of standardization and harmonization of assays such as:
-The International Federation of Clinical Chemistry (IFCC),
-The European Federation of Clinical Chemistry and Laboratory Medicine (EFLM),
- The American Association for Clinical Chemistry (AACC),
- The World Health Organization,
- International Consortium for Harmonization of Clinical Laboratory Results (ICHCLR)
The responsibility for issuing a formal SOP is with the Health Reference Laboratory (RHL). There are several things that need to be coordinated (e.g. sample type, different test accuracy for each sample,etc.), but only a few documents have been publishedIt seems necessary to invite academic members or specialists to form various scientific committees. The task of these committees is to provide specific answers to laboratory questions or to provide specific recommendations and SOPs in each issue (28,29).
EQAS program and Auditing
The Iranian HRL also monitors the quality of diagnostic tests in all clinical diagnostic centers that work with GDLA. They check laboratory conformity using standard guidelines for all clinical laboratories.
They have enough power to point out any problems or introduce them as a well-functioning laboratory. At present, no independent studies are available on the success and weakness of the current quality assurance program in Iranian laboratories, although much effort has been made to implement quality assurance throughout the country (30).
These programs should indeed identify systematic errors in diagnostic procedures that may not be revealed by internal QA processes. In addition, the audit program is another key strategy for controlling weakness and improving laboratory results, and is part of a quality assessment that may in some cases provide better results (e.g. diagnosis of tuberculosis).
The Office of Laboratory Affairs (OLA) of each university has authority in this matter. This office is located in the Vice Chancellor for Treatment of each university and involves in surveillance on clinical laboratories.
The main task of this office is to arrange regular audits, which are currently not done properly. Despite of activity of these authorized bodies with last decade, rout of unreliability and uncertainty of those unique tests has not been reduced. (31).
Undoubtedly, there should be some potential barriers to the effectiveness of our EQAS implementation, such as availability of proficiency testing and the proper conduct of audits in laboratories.
However, it is reported that the regular performance of internal audits is often overlooked. Despite the potential and critical role of auditing in improving the quality of clinical care, the audit evaluation has not been scientifically evaluated or adequately reported.
Technical officer
Some of these uncertainties are obviously related to the laboratory performance. Periodical inspections have revealed some other errors in the routine work of clinical laboratories, even in reputable labs. In fact, the accuracy of all laboratory processes should be supervised by technical authorities. Unfortunately, several reports confirm significant number of technical authorities are unaware on the quality of diagnostic procedures. Laboratories that want to be accredited must participate in training programs or workshops to meet the following standard criteria; trained staff, use of quality control for inspect equipment, availability of approved workspace, valid diagnostic protocols.
In addition, the technical supervisors of each laboratory must have sufficient pathophysiological knowledge about each test to perform or modify diagnosis procedures. These technical assistants are qualified for the best guarantee of using internal and external quality assessment and having successful laboratory quality assurance program (24,31).

Conclusion
The study of the efficient parameters investigated on the performance of laboratory tests shows that various factors play a role in the uncertainty of the answers. Lack of proper supervision law, incompetence of auditors, laboratory costs, staff skills are some of the things that have led to testing in non-standard conditions. Determining the quality of special tests and allocating the appropriate cost
to it can be the most useful measures.

  1. Simundic AM, Nikolac N, Vukasovic I, et al. N. The prevalence of preanalytical errors in a Croatian ISO 15189 accredited laboratory. Clin Chem Lab Med. 2010;48:1009-1014.
  2. Hajia M, Sohrabi A. Current Situation of Molecular Diagnostic Assay in Iran: Is it Necessary to Revise of Health Surveillance System at Laboratory Level? Ind J Clin Biochem, 2020.
  3. Aghaei Hashjin A, Kringos D, Ravaghi H,et al. Application of Quality Assurance Strategies in Diagnostics and Clinical Support Services in Iranian Hospitals. Int J Health Policy Manag. 2015;4:653-661.
  4. Aghaei Hashjin A, Ravaghi H, Kringos DS,et al. Using Quality Measures for Quality Improvement: The Perspective of Hospital Staff. PLoS One. 2014;9:e86014.
  5. Hajia M. Secondary use of laboratory data: potentialities and limitations. Iran J Pathol. 2019;14:188-192.
  6. Plebani M, Sciacovelli L, Aita A ,et al. Quality indicators to detect pre-analytical errors in laboratory testing. Clin Chim Acta. 2014;432:44-48.
  7. Suleiman DE. The persistent problem of diagnostic errors. An Nig Med. 2016;10:1-2
  8. Berner ES, Garber ML. Overconfidence as a Cause of Diagnostic Error in Medicine. Am J Med. 2008;121:S2-23.
  9. Safadel N, Dahim P, Anjarani S, et al. Upgrading the Iranian national laboratory standard. Iran J Public Health. 2013;42:125-128.
  10. Simundic AM, Lippi G. Preanalytical phase – a continuous challenge for laboratory professionals. Biochem Med (Zagreb).2012;22:145-149.
  11. Hickner J, Graham DG, Elder NC, et al. Testing process errors and their harms and consequences reported from family medicine practices: a study of the American Academy of Family Physicians National Research Network. Qual Saf Health Care.2008;17:194-200.
  12. Ravagh H, Abolhassani N, Dahim P, et al. Assessors’ attitudes toward and experiences of national quality standards: A qualitative study in Iran. Int J of Reproductive Bio Med, 2018;16:469-474.
  13. Saber Tehrani AS, Lee H, Mathews SC ,et al. 25-Year summary of US malpractice claims for diagnostic errors 1986-2010: an analysis from the National Practitioner Data Bank. BMJ Qual Saf. 2013;22:672-680.
  14. Hajia M, Safadel N, Samiee SM ,et al. Quality Assurance Program for Molecular Medicine Laboratories. Iran J Public Health.2013;42:119-124.
  15. Epner PL, Gans JE, Graber ML. When diagnostic testing leads to harm: a new outcomes-based approach for laboratory medicine. BMJ Qual Saf. 2013;22:ii6-ii10.
  16. Graber ML. The incidence of diagnostic error in medicine. BMJ Qual Saf. 2013;22:ii33-ii39.
  17. Ely JW, Graber ML. Preventing diagnostic errors in primary care. Am Fam Physician. 2016;94:426-432.
  18. Safadel N, Dahim P, Anjarani S ,et al. Challenges of implementing Iranian national laboratory standards. Iran J Public Health. 2013;42:125-128.
  19. Dahim P, Amini R, Safadel N. Implementation of Quality Management System in Iranian. Medical Laboratories. Iran J Public Health. 2013;42:125-128.
  20. Aghaei Hashjin A, Delgoshaei B, Kringos DS ,et al. Implementation of hospital quality assurance policies in Iran: balancing the role of licensing, annual evaluation, inspections and quality management systems. Int J Health Care Qual Assur. 2015;28:343-355.
  21. Aghaei Hashjin A, Kringos DS, Manoochehri J ,et al. Implementation of patient safety and patient-centeredness strategies in Iranian hospitals. PLoS One. 2014;9:e108831.
  22. Panteghini M, Ceriotti F. Obtaining reference intervals traceable to reference measurement systems: is it possible, who is responsible, what is the strategy? Clin Chem Lab Med. 2011;50:813-817.
  23. Tate JR, Sikaris KA, Jones GR ,et al. Harmonising adult and paediatric reference intervals in Australia and New Zealand: an evidence-based approach for establishing a first panel of chemistry analytes. Clin Biochem Rev. 2014;35:213-235.
  24. Hajia m, Rahnamye MF. Molecular diagnosis of infectious disease: Quality requirement. 2016;14:86 .
  25. Plebani M. Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med. 2013;51:741-751.
  26. Plebani M, Chiozza ML, Sciacovelli L. Towards harmonization of quality indicators in laboratory medicine. Clin Chem Lab Med. 2013;51:187-195.
  27. Tate JR, Johnson R, Barth JH, et al. Harmonization of laboratory testing – current achievements and future strategies. Clin Chim Acta. 2014;432:4-7.
  28. Plebani M. The detection and prevention of errors in laboratory medicine. Ann Clin Biochem. 2010;47:101-110.
  29. Ravaghi H, Abolhassani N, Dahim P, Set al. Assessors’ attitudes toward and experiences of national quality standards: a qualitative study in Iran. Accred Qual Assur. 2014;19:301-305.
  30. Friedman CP, Rubin JC, Sullivan KJ. Toward an Information Infrastructure for Global Health mprovement. Yearb Med Inform.2017;26:16-23.
  31. Hajia M, Sohrabi A. Comment on “Upgrading the Iranian National Laboratory Standard to Conform to ISO 15189: 2012”. Indian Journal of Clinical Biochemistry. 2019; 12:1-2